CD79A and ocular melanoma: Interestingly, in addition to the clinical efficacy, the Authors reported a significant increase in the serum IgA levels and in T lymphocyte counts in the OM-85 treated patients until 3 months after the exacerbation, thus confirming the modulatory role of OM-85 in the immune system.